Viewing Study NCT01543178


Ignite Creation Date: 2025-12-18 @ 9:37 AM
Ignite Modification Date: 2025-12-23 @ 7:05 PM
Study NCT ID: NCT01543178
Status:
Last Update Posted:
First Post:
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
Sponsor:
Organization:

Study Modules

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module